Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Anti-Cancer Drug Design
|
April 1, 1993
In vivo study of vinorelbine associations with cisplatin, 5-fluorouracil or actinomycin D relative to a non-small-cell lung carcinoma (NSCLCN6-L16)
C Roussakis, Y F Pouchus, C Gratas, et al.
Anticancer Research
|
March 12, 1998
Correlation between multidrug resistance and the degree of differentiation of non-small-cell bronchopulmonary carcinoma (NSCLC) in vitro and in vivo
S Bösch, S Siavoshian, C Jacquot, et al.
Anticancer Research
|
May 1, 1996
Terminal differentiation in a non-small-cell bronchopulmonary carcinoma correlates with increased expression of p53
E Liscia, D Riou, S Slavoshian, et al.
Seminars in Oncology
|
February 1, 1990
A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party
J Klastersky, J P Sculier, G Dabouis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1990
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861
J Klastersky, J P Sculier, H Lacroix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1990
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party
J P Sculier, J Klastersky, P Libert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party
M Paesmans, J P Sculier, P Libert, et al.
Clinical Chemistry
|
May 1, 1992
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer
J J Body, M Paesmans, J P Sculier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium
J Klastersky, J P Sculier, G Bureau, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Anti-Cancer Drug Design
|
April 1, 1993
In vivo study of vinorelbine associations with cisplatin, 5-fluorouracil or actinomycin D relative to a non-small-cell lung carcinoma (NSCLCN6-L16)
C Roussakis, Y F Pouchus, C Gratas, et al.
Anticancer Research
|
March 12, 1998
Correlation between multidrug resistance and the degree of differentiation of non-small-cell bronchopulmonary carcinoma (NSCLC) in vitro and in vivo
S Bösch, S Siavoshian, C Jacquot, et al.
Anticancer Research
|
May 1, 1996
Terminal differentiation in a non-small-cell bronchopulmonary carcinoma correlates with increased expression of p53
E Liscia, D Riou, S Slavoshian, et al.
Seminars in Oncology
|
February 1, 1990
A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party
J Klastersky, J P Sculier, G Dabouis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1990
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861
J Klastersky, J P Sculier, H Lacroix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1990
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party
J P Sculier, J Klastersky, P Libert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party
M Paesmans, J P Sculier, P Libert, et al.
Clinical Chemistry
|
May 1, 1992
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer
J J Body, M Paesmans, J P Sculier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium
J Klastersky, J P Sculier, G Bureau, et al.
Page
of 6